Magdolna Herold

10PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapyCancer diagnosisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 27, 2026
Survival Difference in Advanced-Stage Cervical and Ovarian Cancer Patients Treated with Concomitant Modulated Electro-Hyperthermia in Comparison to Classic Treatment Modalities: Results of a Pilot Study and Meta-Analysis.

Ivan Panczel, Magdolna Herold, Erika Borbenyi

|Aug 22, 2025
Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study.

Zoltan Herold, Magdolna Herold, Gyongyver Szentmartoni

|Sep 28, 2023
High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer.

Andras Jozsef Barna, Zoltan Herold, Miklos Acs

|Sep 28, 2023
The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience.

Magdolna Dank, Dorottya Mühl, Annamária Pölhös

|Feb 11, 2023
Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas.

Attila Marcell Szasz, Elisabeth Estefanía Arrojo Alvarez, Giammaria Fiorentini

|Aug 26, 2022
Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?

Magdolna Dank, Dorottya Mühl, Magdolna Herold

Pageof 2

Frequent Collaborators

10 joint publications

Zoltan Herold

6 joint publications

Magdolna Dank

2 joint publications

Klara Rosta

2 joint publications

Aniko Somogyi